Related Experiment Video
Updated: May 17, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Clinical presentation and evaluation of dermatomyositis
Umaima Marvi1, Lorinda Chung, David F Fiorentino
1Division of Immunology and Rheumatology, Stanford University, USA.
Dermatomyositis (DM) is an immune-mediated inflammatory disease affecting skin and muscles. Early evaluation for associated malignancy is crucial for patients diagnosed with DM.
Area of Science:
- Immunology
- Rheumatology
- Dermatology
Background:
- Dermatomyositis (DM) is a chronic inflammatory disorder impacting skin and muscles.
- Evidence indicates DM is immune-mediated, with 50-70% of patients having myositis-specific auto-antibodies.
- Interferon signaling is upregulated in DM patients' muscle, blood, and skin.
Purpose of the Study:
- To review the immunopathogenesis of DM.
- To summarize clinical manifestations of DM.
- To outline the evaluation of DM patients.
Main Methods:
- Review of existing literature on DM.
- Analysis of gene expression data.
- Summary of clinical presentation and diagnostic methods.
Main Results:
- DM presents with proximal muscle weakness and characteristic skin lesions (e.g., heliotrope rash, Gottron's papules).
- Associated conditions include interstitial lung disease, dysphagia, and Raynaud phenomenon.
- DM patients have a 3-8 times increased risk of malignancy.
Conclusions:
- DM is an immune-mediated disease with diverse clinical manifestations.
- Comprehensive evaluation including malignancy screening is essential for DM patients.
- Understanding immunopathogenesis guides clinical management and diagnosis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
